Efficacy of modafinil on excessive daytime sleepiness in Prader-Willi syndrome

American Journal of Medical Genetics, Part A

Volumn 155, Issue 7, 2011, Pages 1552-1557

  De Cock, V Cochen ^a   Diene, G ^b   Molinas, C ^b   Masson, V Dauriac Le ^c   Kieffer, I ^b   Mimoun, E ^b   Tiberge, M ^d   Tauber, M ^b  

^a CHU PURPAN   (France)

^b HÔPITAL DES ENFANTS   (France)

^c CENTRE HOSPITALIER SAINTE ANNE   (France)

^d CHU RANGUEIL   (France)

Author keywords

Daytime sleepiness; Modafinil; Prader Willi syndrome

Indexed keywords

MODAFINIL;

ABSENCE OF SIDE EFFECTS; ADOLESCENT; ADULT; ANXIETY; ARTICLE; BODY MASS; CASE STUDY; CHILD; CLINICAL ARTICLE; DAYTIME SOMNOLENCE; DRUG EFFICACY; DRUG TOLERABILITY; EPWORTH SLEEPINESS SCALE; FEMALE; HEADACHE; HUMAN; INSOMNIA; MALE; NARCOLEPSY; NAUSEA; OPEN STUDY; PHENOTYPE; PILOT STUDY; PRADER WILLI SYNDROME; PRIORITY JOURNAL; REM SLEEP; SCHOOL CHILD; SIDE EFFECT; TREATMENT DURATION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; BENZHYDRYL COMPOUNDS; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; DISORDERS OF EXCESSIVE SOMNOLENCE; FEMALE; HUMANS; MALE; PILOT PROJECTS; PRADER-WILLI SYNDROME; SLEEP STAGES; YOUNG ADULT;

EID: 79959531958     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.34047     Document Type: Article

References (35)

1. Aldrich MS, Chervin RD, Malow BA. 1997. Value of the multiple sleep latency test (MSLT) for the diagnosis of narcolepsy. Sleep 20: 620-629.
2. American Academy of Sleep Medicine Task Force. 1999. Sleep-related breathing disorders in adults: Recommendations for syndrome definition and measurement techniques in clinical research. The Report of an American Academy of Sleep Medicine Task Force. Sleep 22: 667-689.
3. American Sleep Disorders Association. 1992. EEG arousals: Scoring rules and examples: A preliminary report from the Sleep Disorders Atlas Task Force of the American Sleep Disorders Association. Sleep 15: 173-184.
4. American Thoracic Society. 1996. Standards and indications for cardiopulmonary sleep studies in children. Am J Respir Crit Care Med 153: 866-878.
5. Annane D, Moore DH, Barnes PR, Miller RG. 2006. Psychostimulants for hypersomnia (excessive daytime sleepiness) in myotonic dystrophy. Cochrane Database Syst Rev 3: CD003218.
6. Beusterien KM, Rogers AE, Walsleben JA, Emsellem HA, Reblando JA, Wang L, Goswami M, Steinwald B. 1999. Health-related quality of life effects of modafinil for treatment of narcolepsy. Sleep 22: 757-765.
7. Bischof JM, Stewart CL, Wevrick R. 2007. Inactivation of the mouse Magel2 gene results in growth abnormalities similar to Prader-Willi syndrome. Hum Mol Genet 16: 2713-2719.
8. Butler JV, Whittington JE, Holland AJ, Boer H, Clarke D, Webb T. 2002. Prevalence of, and risk factors for, physical ill-health in people with Prader-Willi syndrome: A population-based study. Dev Med Child Neurol 44: 248-255.
9. Cassidy SB, McKillop JA, Morgan WJ. 1990. Sleep disorders in Prader-Willi syndrome. Dysmorphol Clin Genet 4: 13-17.
10. Clift S, Dahlitz M, Parkes JD. 1994. Sleep apnoea in the Prader-Willi syndrome. J Sleep Res 3: 121-126.
11. Cole TJ, Bellizzi MC, Flegal KM, Dietz WH. 2000. Establishing a standard definition for child overweight and obesity worldwide: International survey. Br Med J 320: 1240-1243.
12. Cotton S, Richdale A. 2006. Brief report: Parental descriptions of sleep problems in children with autism, Down syndrome, and Prader-Willi syndrome. Res Dev Disabil 27: 151-161.
13. Ferraro L, Tanganelli S, O'Connor WT, Antonelli T, Rambert F, Fuxe K. 1996. The vigilance promoting drug modafinil decreases GABA release in the medial preoptic area and in the posterior hypothalamus of the awake rat: Possible involvement of the serotonergic 5-HT3 receptor. Neurosci Lett 220: 5-8.
14. Group UMiNMS. 2000. Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy: US Modafinil in Narcolepsy Multicenter Study Group. Neurology 54: 1166-1175.
15. Harris JC, Allen RP. 1996. Is excessive daytime sleepiness characteristic of Prader-Willi syndrome? The effects of weight change. Arch Pediatr Adolesc Med 150: 1288-1293.
16. Heussler H, Harris M, Cooper D. 2008. Hypersomnolence in Prader-Willi Syndrome. J Intellect Disabil Res 52: 814.
17. Holm VA, Cassidy SB, Butler MG, Hanchett JM, Greenswag LR, Whitman BY, Greenberg F. 1993. Prader-Willi syndrome: Consensus diagnostic criteria. Pediatrics 91: 398-402.
18. Johns MW. 1991. A new method for measuring daytime sleepiness: The Epworth sleepiness scale. Sleep 14: 540-545.
19. Kozlov SV, Bogenpohl JW, Howell MP, Wevrick R, Panda S, Hogenesch JB, Muglia LJ, Van Gelder RN, Herzog ED, Stewart CL. 2007. The imprinted gene Magel2 regulates normal circadian output. Nat Genet 39: 1266-1272.
20. Makris AP, Rush CR, Frederich RC, Kelly TH. 2004. Wake-promoting agents with different mechanisms of action: Comparison of effects of modafinil and amphetamine on food intake and cardiovascular activity. Appetite 42: 185-195.
21. Manni R, Politini L, Nobili L, Ferrillo F, Livieri C, Veneselli E, Biancheri R, Martinetti M, Tartara A. 2001. Hypersomnia in the Prader-Willi syndrome: Clinical-electrophysiological features and underlying factors. Clin Neurophysiol 112: 800-805.
22. Melendres MC, Lutz JM, Rubin ED, Marcus CL. 2004. Daytime sleepiness and hyperactivity in children with suspected sleep-disordered breathing. Pediatrics 114: 768-775.
23. Molinas C, Cazals L, Diene G, Glattard M, Arnaud C, Tauber M. 2008. French database of children and adolescents with Prader-Willi syndrome. BMC Med Genet 9: 89.
24. Nevsimalova S, Vankova J, Stepanova I, Seemanova E, Mignot E, Nishino S. 2005. Hypocretin deficiency in Prader-Willi syndrome. Eur J Neurol 12: 70-72.
25. Nixon GM, Brouillette RT. 2002. Sleep and breathing in Prader-Willi syndrome. Pediatr Pulmonol 34: 209-217.
26. O'Donoghue FJ, Camfferman D, Kennedy JD, Martin AJ, Couper T, Lack LD, Lushington K, McEvoy RD. 2005. Sleep-disordered breathing in Prader-Willi syndrome and its association with neurobehavioral abnormalities. J Pediatr 147: 823-829.
27. Parkes JD. 1999. Genetic factors in human sleep disorders with special reference to Norrie disease, Prader-Willi syndrome and Moebius syndrome. J Sleep Res 8: 14-22.
28. Priano L, Grugni G, Miscio G, Guastamacchia G, Toffolet L, Sartorio A, Mauro A. 2006. Sleep cycling alternating pattern (CAP) expression is associated with hypersomnia and GH secretory pattern in Prader-Willi syndrome. Sleep Med 7: 627-633.
29. Loi n°2004-806 du 9 août 2004 relative à la politique de santé publique; Journal Officiel de la République Française n°185 du 11 août 2004; p 14277, tescte n°4.
30. Rechtschaffen A, Kales A. 1968. A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects: UCLA Brain Information Service/Brain Research Institute.
31. Talbot K, Stradling J, Crosby J, Hilton-Jones D. 2003. Reduction in excess daytime sleepiness by modafinil in patients with myotonic dystrophy. Neuromuscul Disord 13: 357-364.
32. Vela-Bueno A, Kales A, Soldatos CR, Dobladez-Blanco B, Campos-Castello J, Espino-Hurtado P, Olivan-Palacios J. 1984. Sleep in the Prader-Willi syndrome. Clinical and polygraphic findings. Arch Neurol 41: 294-296.
33. Vgontzas AN, Bixler EO, Kales A, Centurione A, Rogan PK, Mascari M, Vela-Bueno A. 1996. Daytime sleepiness and REM abnormalities in Prader-Willi syndrome: Evidence of generalized hypoarousal. Int J Neurosci 87: 127-139.
34. Waters J, Clarke DJ, Corbett JA. 1990. Educational and occupational outcome in Prader-Willi syndrome. Child Care Health Dev 16: 271-282.
35. Williams K, Scheimann A, Sutton V, Hayslett E, Glaze DG. 2008. Sleepiness and sleep disordered breathing in Prader-Willi syndrome: Relationship to genotype, growth hormone therapy, and body composition. J Clin Sleep Med 4: 111-118.